You need to enable JavaScript to run this app.
FDA’s document-based inspections prompt warning letters for GMP violations
Regulatory News
Joanne S. Eglovitch
Compliance
North America
Pharmaceuticals
Quality Assurance and Control
Regulatory Intelligence/Policy